Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51
United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Glenn P Muir
7 May 2026
Director
Exercised, kept
2,434
$38.76
$94.34K
Glenn P Muir
16 Dec 2025
Director
Exercised, kept
3,366
$26.12
$87.92K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 18
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 145,954
History held since 6 Dec 2006